9 results match your criteria: "The Erlanger Heart and Lung Institute[Affiliation]"
Circ Cardiovasc Interv
February 2024
Department of Medicine, Division of Cardiology (R.P., R.R.M., N.J., B.R.L.), Vanderbilt University Medical Center, Nashville, TN.
Circulation
August 2023
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (S.M.A.-K.).
JACC Cardiovasc Interv
June 2023
Division of Cardiology, Department of Medicine, University of Tennessee-Chattanooga, The Erlanger Heart and Lung Institute, Chattanooga, Tennessee, USA. Electronic address:
J Am Coll Cardiol
February 2023
Cardiovascular Medicine, Baylor Scott and White, The Heart Hospital Plano, Plano, Texas, USA.
JACC Adv
December 2022
Department of Cardiology, Mayo Clinic School of Medicine, Rochester, Minnesota, USA.
The field of left atrial appendage occlusion is rapidly evolving. However, several issues remain including the limited randomized efficacy data, peri-device leak, device-related thrombus, and the ongoing refinement of procedural techniques. In this article, we provide a contemporary overview of left atrial appendage occlusion focusing on 4 key remaining challenges: efficacy data, peri-device leak, device-related thrombus, and procedural optimization.
View Article and Find Full Text PDFPLoS One
August 2022
Department of Cardiovascular Medicine, The Erlanger Heart and Lung Institute, Chattanooga, Tennessee, United States of America.
Background: Guidelines recommend including the patient's values and preferences when choosing treatment for severe aortic stenosis (sAS). However, little is known about what matters most to patients as they develop treatment preferences. Our objective was to identify, prioritize, and organize patient-reported goals and features of treatment for sAS.
View Article and Find Full Text PDFBackground Left ventricular hypertrophy (LVH) is associated with increased mortality risk and rehospitalization after transcatheter aortic valve replacement among those with severe aortic stenosis. Whether cardiac troponin (cTnT) and NT-proBNP (N-terminal pro-B-type natriuretic peptide) risk stratify patients with aortic stenosis and without LVH is unknown. Methods and Results In a multicenter prospective registry of 923 patients with severe aortic stenosis undergoing transcatheter aortic valve replacement, we included 674 with core-laboratory-measured LV mass index, cTnT, and NT-proBNP.
View Article and Find Full Text PDFAm J Med
May 2022
Division of Cardiovascular Medicine, The Erlanger Heart and Lung Institute, Chattanooga, TN. Electronic address:
Background: For 2 decades, women have made up nearly half of medical school graduates, yet this has not translated to equity in promotion. We compare historical trends in the academic career pipeline among 4 specialties by sex.
Methods: Using the Association of American Medical Colleges database, faculty sex and rank were examined in oncology, gastroenterology, cardiovascular medicine, and general surgery for the years 2000 and 2020.
J Am Coll Cardiol
December 2021
Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval, Québec City, Québec, Canada.